Many Alzheimer’s Consultants Say Use of Aduhelm Ought to Be Sharply Restricted
Dr. Selloway, a research director on the site for studies of the drug, was not paid for this work but has received research and consulting fees from Biogen. He said doctors should only use the drug on patients whose status matches those…